Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Tax Rate readings, the most recent being 30.87% for Q1 2026.

  • On a quarterly basis, Tax Rate fell 1427.0% to 30.87% in Q1 2026 year-over-year; TTM through Mar 2026 was 31.07%, a 74949.0% decrease, with the full-year FY2025 number at 33.6%, up 5833.0% from a year prior.
  • Tax Rate hit 30.87% in Q1 2026 for Kiniksa Pharmaceuticals International, down from 38.98% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1308.39% in Q2 2023 to a low of 379.5% in Q3 2022.
  • Median Tax Rate over the past 5 years was 2.7% (2022), compared with a mean of 72.37%.
  • Biggest five-year swings in Tax Rate: soared 131211bps in 2023 and later crashed -103878bps in 2024.
  • Kiniksa Pharmaceuticals International's Tax Rate stood at 2.7% in 2022, then plummeted by -466bps to 15.27% in 2023, then skyrocketed by 669bps to 86.95% in 2024, then plummeted by -55bps to 38.98% in 2025, then dropped by -21bps to 30.87% in 2026.
  • The last three reported values for Tax Rate were 30.87% (Q1 2026), 38.98% (Q4 2025), and 32.12% (Q3 2025) per Business Quant data.